Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading

Investigative Radiology

Volumn 50, Issue 4, 2015, Pages 290-296

  Yoon, Jeong Hee ^a   Lee, Jeong Min ^a,b   Klotz, Ernst ^a   Jeon, Ju Hyun ^a   Lee, Kyung Bun ^a   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Computed tomography; Hepatic extracellular volume fraction; Hepatic fibrosis; Liver

Indexed keywords

ADULT; AORTA; AREA UNDER THE CURVE; ARTICLE; COMPENSATED LIVER CIRRHOSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DECOMPENSATED LIVER CIRRHOSIS; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE SUBTRACTION; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAGING; LIVER; LIVER CIRRHOSIS; ORGAN SIZE; PATHOLOGY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ORGAN SIZE; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925271274     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000123     Document Type: Article

References (27)

1. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol. 2003;38(supp 1):S38-S53.
2. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology. 2002;122:1525-1528.
3. Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 2003;327:143-147.
4. Shiffman ML, Hofmann CM, Contos MJ, et al. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology. 1999;117:1164-1172.
5. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
6. McGill D, Rakela J, Zinsmeister A, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99:1396-1400.
7. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15-20.
8. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449-1457.
9. Ferraioli G, Tinelli C, Dal Bello B, et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56:2125-2133.
10. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index1. Radiology. 2007;245:458-466.
11. Yoon JH, Lee JM, Woo HS, et al. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol. 2013;14:202-212.
12. Choi YR, Lee JM, Yoon JH, et al. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Invest Radiol. 2013;48:607-613.
13. Yoon JH, Lee JM, Han JK, et al. Shear wave elastography for liver stiffness measurement in clinical sonographic examinations evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements. J Ultrasound Med. 2014;33:437-447.
14. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.
15. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
16. Varenika V, Fu Y, Maher JJ, et al. Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology. 2013;266:151-158.
17. Zissen MH, Wang ZJ, Yee J, et al. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. Am J Roentgenol. 2013;201:1204-1210.
18. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99:1160-1174.
19. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology. 1999;211:698-708.
20. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289-293.
21. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994;20:15-20.
22. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet. 1968;2:626-628.
23. Van Beers BE, Leconte I, Materne R, et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol. 2001;176:667-673.
24. Guan S, Zhao W-D, Zhou K-R, et al. CT perfusion at early stage of hepatic diffuse disease. World J Gastroenterol. 2005;11:3465-3467.
25. Chao D, Lim J, Ayoub W, et al. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase≤40 IU/L and significant hepatic fibrosis. Aliment Pharmacol Ther. 2014;39:349-358.
26. Dawson P, Morgan J. The meaning and significance of the equilibrium phase in enhanced computed tomography of the liver. Br J Radiol. 1999;72:438-442.
27. Hagiwara M, Rusinek H, Lee VS, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience1. Radiology. 2008;246:926-934.